Videos / A triple-therapy combination inhaler for moderate to very severe COPD
In this Product Explainer, Prof Christine Jenkins, Head of the Respiratory Group at The George Institute for Global Health; and Senior Staff Specialist in Thoracic Medicine at Concord Hospital explains the role of a triple-therapy combination, pressurised meter dose inhaler for adults with moderate to very severe COPD. (4 mins).
Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence
Genitourinary Syndrome of Menopause – Mythbusting for GPs
Dysmenorrhoea in Teens
Winter Virus Preparations
expert
Respiratory Physician; Head, Respiratory Group, The George Institute for Global Health